News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
63,528 Results
Type
Article (1769)
Company Profile (5)
Press Release (61754)
Section
Business (28779)
Career Advice (55)
Deals (4268)
Drug Delivery (3)
Drug Development (7362)
Employer Resources (9)
FDA (1225)
Job Trends (1822)
News (39680)
Policy (2012)
Tag
Academia (108)
Adcomms (1)
Allergies (10)
Alliances (2172)
ALS (13)
Alzheimer's disease (140)
Antibody-drug conjugate (ADC) (26)
Approvals (1275)
Artificial intelligence (32)
Autoimmune disease (20)
Automation (4)
Bankruptcy (12)
Best Places to Work (1695)
Biosimilars (16)
Biotechnology (6)
Bladder cancer (21)
Brain cancer (6)
Breast cancer (87)
Cancer (483)
Cardiovascular disease (42)
Career advice (52)
Career pathing (3)
CAR-T (14)
CDC (1)
Cell therapy (48)
Cervical cancer (2)
Clinical research (6921)
Collaboration (86)
Company closure (1)
Compensation (85)
Complete response letters (3)
COVID-19 (160)
CRISPR (6)
C-suite (44)
Cystic fibrosis (9)
Data (775)
Depression (10)
Diabetes (48)
Diagnostics (704)
Digital health (6)
Diversity, equity & inclusion (1)
Drug discovery (14)
Drug pricing (3)
Duchenne muscular dystrophy (12)
Earnings (27252)
Editorial (2)
Employer branding (1)
Employer resources (6)
Events (6297)
Executive appointments (31)
FDA (1644)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (6)
Funding (99)
Gene editing (14)
Generative AI (4)
Gene therapy (40)
GLP-1 (87)
Government (211)
Guidances (252)
Healthcare (1750)
HIV (4)
Huntington's disease (1)
IgA nephropathy (9)
Immunology and inflammation (26)
Immuno-oncology (2)
Indications (16)
Infectious disease (174)
Inflammatory bowel disease (25)
Influenza (4)
Intellectual property (20)
Interviews (2)
IPO (3228)
IRA (2)
Job creations (186)
Job search strategy (46)
Kidney cancer (1)
Labor market (13)
Layoffs (38)
Leadership (1)
Legal (331)
Liver cancer (11)
Lung cancer (69)
Lymphoma (52)
Management (4)
Manufacturing (33)
MASH (25)
Medical device (1499)
Medtech (1505)
Mergers & acquisitions (1110)
Metabolic disorders (125)
Multiple sclerosis (25)
NASH (2)
Neurodegenerative disease (21)
Neuropsychiatric disorders (12)
Neuroscience (279)
NextGen: Class of 2026 (416)
Non-profit (206)
Now hiring (7)
Obesity (52)
Opinion (4)
Ovarian cancer (11)
Pain (6)
Pancreatic cancer (17)
Parkinson's disease (32)
Partnered (2)
Patents (35)
Patient recruitment (26)
Peanut (4)
People (1939)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase 1 (1633)
Phase 2 (2732)
Phase 3 (3024)
Pipeline (1453)
Policy (4)
Postmarket research (278)
Preclinical (431)
Press Release (4)
Prostate cancer (22)
Psychedelics (3)
Radiopharmaceuticals (24)
Rare diseases (57)
Real estate (222)
Recruiting (3)
Regulatory (1732)
Reports (11)
Research institute (128)
Resumes & cover letters (4)
Rett syndrome (8)
RSV (5)
Schizophrenia (24)
Series A (12)
Series B (14)
Sickle cell disease (9)
Special edition (3)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (113)
Stomach cancer (3)
Supply chain (5)
Tariffs (2)
The Weekly (2)
Vaccines (41)
Venture capital (7)
Weight loss (25)
Women's health (8)
Worklife (2)
Date
Today (40)
Last 7 days (87)
Last 30 days (213)
Last 365 days (4060)
2026 (313)
2025 (4075)
2024 (4490)
2023 (5311)
2022 (5870)
2021 (6220)
2020 (5176)
2019 (4244)
2018 (3267)
2017 (2857)
2016 (2109)
2015 (3159)
2014 (2237)
2013 (1179)
2012 (1456)
2011 (1589)
2010 (1646)
Location
Africa (48)
Alabama (6)
Arizona (11)
Asia (3414)
Australia (401)
California (1320)
Canada (448)
China (105)
Colorado (56)
Connecticut (76)
Delaware (52)
Europe (9228)
Florida (181)
Georgia (45)
Idaho (4)
Illinois (94)
India (5)
Indiana (92)
Iowa (1)
Japan (52)
Kansas (14)
Kentucky (5)
Louisiana (7)
Maine (20)
Maryland (180)
Massachusetts (1053)
Michigan (31)
Minnesota (80)
Missouri (11)
Montana (3)
Nevada (16)
New Hampshire (15)
New Jersey (477)
New York (456)
North Carolina (202)
North Dakota (1)
Northern California (713)
Ohio (28)
Pennsylvania (258)
South America (84)
Southern California (497)
Tennessee (15)
Texas (201)
United States (5062)
Utah (46)
Virginia (20)
Washington D.C. (4)
Washington State (116)
Wisconsin (10)
63,528 Results for "57".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health
January 12, 2026
·
4 min read
Press Releases
Botox Market Size to worth US$ 12.57 Billion by 2032, Coherent Market Insights
January 13, 2026
·
1 min read
Press Releases
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
February 10, 2026
·
4 min read
Cardiovascular disease
Novo’s Wegovy Cuts Cardio Risk by 57% Versus Tirzepatide
Novo Nordisk’s Wegovy has been on a winning streak as of late, with a metabolic dysfunction-associated steatohepatitis approval last month and prime position in the oral obesity race.
September 2, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
Novartis and Monte Rosa first partnered in October 2024 for a molecular glue asset for immune-mediated and autoimmune diseases. This time, the pharma is putting $120 million down upfront for more of the biotech’s AI-discovered degraders.
September 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Champions Oncology Reports Record Annual Revenue of $57 Million
July 24, 2025
·
15 min read
Press Releases
Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility
October 2, 2025
·
4 min read
FDA
FDA Went Against Adcomm Votes More, Held Fewer Meetings in 2025
In a year that saw advisory committees placed under a particularly bright microscope at the FDA, the agency held fewer meetings than usual and agreed with its advisors only 57% of the time, Jefferies reported.
January 6, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
August 24, 2025
·
4 min read
Press Releases
Generative AI in Personalized Medicine Market Size Worth USD 57.33 Billion by 2034 Driven by Rising Demand for Precision Therapies and Advanced AI Models
August 27, 2025
·
1 min read
1 of 6,353
Next
